CS
TNDM icon

Credit Suisse’s Tandem Diabetes Care TNDM Stock Holding History

Credit Suisse’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$3.21M Buy
90,763
+1,623
+2% +$43.5K ﹤0.01% 1563
2023
Q4 		$2.64M Buy
89,140
+3,458
+4% +$71.7K ﹤0.01% 1723
2023
Q3 		$1.78M Sell
85,682
-2,480
-3% -$68.1K ﹤0.01% 1898
2023
Q2 		$2.16M Buy
88,162
+6,653
+8% +$214K ﹤0.01% 1858
2023
Q1 		$3.31M Sell
81,509
-1,674
-2% -$69.3K ﹤0.01% 1571
2022
Q4 		$3.74M Buy
83,183
+16,209
+24% +$734K ﹤0.01% 1489
2022
Q3 		$3.21M Buy
66,974
+1,607
+2% +$88.1K ﹤0.01% 1532
2022
Q2 		$3.87M Sell
65,367
-99,095
-60% -$8.14M ﹤0.01% 1473
2022
Q1 		$19.1M Sell
164,462
-312,015
-65% -$36.4M 0.02% 787
2021
Q4 		$71.7M Sell
476,477
-561,069
-54% -$75.7M 0.04% 487
2021
Q3 		$124M Sell
1,037,546
-644,831
-38% -$71M 0.07% 293
2021
Q2 		$164M Sell
1,682,377
-345,220
-17% -$30.8M 0.09% 229
2021
Q1 		$179M Buy
2,027,597
+621,872
+44% +$57.8M 0.09% 234
2020
Q4 		$135M Buy
1,405,725
+658,890
+88% +$67.9M 0.07% 310
2020
Q3 		$84.8M Buy
746,835
+180,579
+32% +$19M 0.05% 402
2020
Q2 		$56M Sell
566,256
-17,783
-3% -$1.42M 0.04% 495
2020
Q1 		$37.6M Sell
584,039
-25,045
-4% -$1.75M 0.03% 535
2019
Q4 		$36.3M Buy
609,084
+100,786
+20% +$6.22M 0.03% 717
2019
Q3 		$30M Sell
508,298
-14,202
-3% -$907K 0.03% 694
2019
Q2 		$33.7M Buy
522,500
+112,031
+27% +$7.23M 0.03% 636
2019
Q1 		$26.1M Buy
410,469
+305,619
+291% +$16.1M 0.02% 717
2018
Q4 		$3.98M Buy
104,850
+93,194
+800% +$3.29M ﹤0.01% 1747
2018
Q3 		$499K Sell
11,656
-984
-8% -$34.4K ﹤0.01% 3298
2018
Q2 		$278K Buy
+12,640
New +$155K ﹤0.01% 3650
2017
Q2 		– Sell
-2,171
Closed -$26K – 3954
2017
Q1 		$26K Buy
+2,171
New +$47.5K ﹤0.01% 3767
2015
Q4 		– Sell
-1,780
Closed -$157K – 4361
2015
Q3 		$157K Sell
1,780
-807
-31% -$93.9K ﹤0.01% 4009
2015
Q2 		$281K Buy
2,587
+875
+51% +$109K ﹤0.01% 4052
2015
Q1 		$216K Sell
1,712
-30
-2% -$3.9K ﹤0.01% 4042
2014
Q4 		$221K Buy
+1,742
New +$242K ﹤0.01% 4226

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Credit Suisse's TNDM Position: Q1 2024 in Review

Credit Suisse increased its Tandem Diabetes Care (TNDM) stake by 1.8% in Q1 2024, buying an estimated $43.5K and bringing the position to 90,763 shares worth $3.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1563.

Credit Suisse first reported a position in TNDM in Q4 2014 and has held it in 29 quarters since. The position peaked at $179M in Q1 2021. 291 funds tracked by Wall St. Rank hold TNDM as of Q1 2024.

  • Credit Suisse held 90,763 shares of Tandem Diabetes Care worth $3.21M as of Q1 2024.
  • Credit Suisse bought 1,623 Tandem Diabetes Care shares in Q1 2024, an estimated $43.5K.
  • Tandem Diabetes Care made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1563 holding.
  • Credit Suisse first reported a position in Tandem Diabetes Care in Q4 2014 and has held it in 29 quarters since.
  • Credit Suisse's Tandem Diabetes Care position peaked at $179M in Q1 2021.
  • 291 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.